Showing results (331-340 of 343) with videos related to

Sort By:
Pageof 35
Regulatory Peptides|November 14, 1996
Neuropeptide Y 3-36 is an endogenous ligand selective for Y2 receptorsD Grandt, M Schimiczek, W Rascher, et al.
The American Journal of Physiology|July 1, 1990
Distinction of NPY receptors in vitro and in vivo. II. Differential effects of NPY and NPY-(18-36)N A Scott, M C Michel, J H Boublik, et al.
European Journal of Pharmacology|October 14, 1994
[Pro34]peptide YY is a Y1-selective agonist at peptide YY/neuropeptide Y receptorsD Grandt, F Feth, W Rascher, et al.
Deutsche Medizinische Wochenschrift (1946)|November 4, 2011
[Expert consensus statement on interventional renal sympathetic denervation for hypertension treatment]F Mahfoud, O Vonend, H Bruck, et al.
Cardiovascular Research|August 6, 1999
L-type calcium current and contractility in ventricular myocytes from mice overexpressing the cardiac beta 2-adrenoceptorJ F Heubach, I Trebess, E Wettwer, et al.
Circulation|May 20, 1999
Myocardial dysfunction in donor hearts. A possible etiologyV J Owen, P B Burton, M C Michel, et al.
Pharmacogenetics|May 8, 2001
In-vivo studies do not support a major functional role for the Gly389Arg beta 1-adrenoceptor polymorphism in humansR Büscher, H Belger, K J Eilmes, et al.
The American Journal of Medicine|January 1, 1989
Elevation of plasma neuropeptide Y levels in congestive heart failureA S Maisel, N A Scott, H J Motulsky, et al.
The American Journal of Physiology|July 1, 1990
Distinction of NPY receptors in vitro and in vivo. I. NPY-(18-36) discriminates NPY receptor subtypes in vitroM C Michel, E Schlicker, K Fink, et al.
International Journal of Clinical Practice|November 26, 2009
Urinary urgency - translating the evidence base into daily clinical practiceL Cardozo, C R Chapple, R Dmochowski, et al.
Pageof 35